Close X
Tuesday, November 26, 2024
ADVT 
National

Avalanche warning for B.C. and Alberta backcountry

Darpan News Desk The Canadian Press, 20 Jan, 2022 12:45 PM
  • Avalanche warning for B.C. and Alberta backcountry

REVELSTOKE, B.C. - A special avalanche warning has been posted for recreational backcountry users in several regions of B.C. and Alberta as warm temperatures make the snowpack unstable.

Avalanche Canada and Parks Canada have issued the advisory to take effect immediately and last through to Monday.

The warning applies to the North and South Columbias, Purcells, Kootenay Boundary, and Glacier, Banff, Yoho and Kootenay National Parks.

It also applies to B.C.'s Sea-to-Sky region and South Coast Inland area from Squamish to Pemberton.

James Floyer, the forecasting program supervisor for Avalanche Canada, says there are weak layers in the mountain snowpack across most of southern B.C. and western Alberta.

He says the combination of the snowpack structure, sunshine and higher temperatures will make natural and human-triggered avalanches much more likely.

The forecasting agency says there have been several close calls reported recently including one last weekend in southeastern B.C. where a large avalanche buried all but the head of a snowmobiler and his companions were able to dig him out alive.

"There is a lot of uncertainty with these weak layers,” says Floyer. "While we have targeted an area where we think there is a higher risk of triggering these deep weak layers, we also urge backcountry users in adjacent regions to exercise caution during this warming period.”

 

MORE National ARTICLES

Protective equipment still scarce for some nurses

Protective equipment still scarce for some nurses
While early indications showed the virus was spread by droplets that settled on surfaces, Silas, president of the Canadian Federation of Nurses, urged health authorities to learn from the SARS outbreak of 2003 and take the highest level of precaution.    

Protective equipment still scarce for some nurses

COVID-19 hospitalizations to surge: Tam

COVID-19 hospitalizations to surge: Tam
Though the rate of people who are hospitalized with Omicron is lower compared to the Delta variant, the forecast shows new daily hospital admissions will far exceed previous historical peaks due to the sheer number of cases.

COVID-19 hospitalizations to surge: Tam

Omicron upends mathematical models tracking COVID

Omicron upends mathematical models tracking COVID
Everything from who gets tested to who's most likely to contract the virus has changed with the latest wave of the pandemic, and that's posing distinct challenges for those who model its impact, says Caroline Colijn, an associate professor of mathematics at Simon Fraser University in British Columbia.

Omicron upends mathematical models tracking COVID

O'Toole opposes Quebec's plan to tax unvaccinated

O'Toole opposes Quebec's plan to tax unvaccinated
The Tory leader made his position known on Premier François Legault's proposal during a Facebook Liveevent late Thursday. Some of his MPs had already taken to social media to condemn the proposal as discriminatory, unethical and punishing to low-income earners.

O'Toole opposes Quebec's plan to tax unvaccinated

B.C. funds OD prevention in construction industry

B.C. funds OD prevention in construction industry
Sheila Malcolmson, the minister of mental health and addictions, says the program dubbed the Tailgate Toolkit was developed on Vancouver Island last year in partnership with people in the industry who have experience with illicit drug use.    

B.C. funds OD prevention in construction industry

Health Canada decision on Pfizer antiviral close

Health Canada decision on Pfizer antiviral close
Canadian health leaders and some premiers have been publicly pressuring Health Canada to greenlight the medication, which prevents the SARS-CoV-2 virus that causes COVID-19 from reproducing within a patient's body. Pfizer's clinical trial showed for high-risk patients it prevented hospitalizations by about 90 per cent.

Health Canada decision on Pfizer antiviral close